AFYREN SAS (ALAFY.PA) Fundamental Analysis & Valuation

EPA:ALAFY • FR0014005AC9

Current stock price

2.185 EUR
+0.09 (+4.3%)
Last:

This ALAFY.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALAFY.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALAFY has reported negative net income.
  • In the past year ALAFY has reported a negative cash flow from operations.
  • In the past 5 years ALAFY always reported negative net income.
  • ALAFY had a negative operating cash flow in each of the past 5 years.
ALAFY.PA Yearly Net Income VS EBIT VS OCF VS FCFALAFY.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -5M -10M

1.2 Ratios

  • ALAFY's Return On Assets of -21.40% is on the low side compared to the rest of the industry. ALAFY is outperformed by 87.14% of its industry peers.
  • The Return On Equity of ALAFY (-23.13%) is worse than 81.43% of its industry peers.
Industry RankSector Rank
ROA -21.4%
ROE -23.13%
ROIC N/A
ROA(3y)-17.22%
ROA(5y)-13.28%
ROE(3y)-19.05%
ROE(5y)-14.95%
ROIC(3y)N/A
ROIC(5y)N/A
ALAFY.PA Yearly ROA, ROE, ROICALAFY.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30

1.3 Margins

  • The Gross Margin of ALAFY (72.15%) is better than 98.57% of its industry peers.
  • ALAFY's Gross Margin has declined in the last couple of years.
  • ALAFY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 72.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.55%
GM growth 5Y-5.98%
ALAFY.PA Yearly Profit, Operating, Gross MarginsALAFY.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. ALAFY.PA Health Analysis

2.1 Basic Checks

  • ALAFY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ALAFY has been increased compared to 1 year ago.
  • Compared to 5 years ago, ALAFY has more shares outstanding
  • Compared to 1 year ago, ALAFY has an improved debt to assets ratio.
ALAFY.PA Yearly Shares OutstandingALAFY.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
ALAFY.PA Yearly Total Debt VS Total AssetsALAFY.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

  • ALAFY has an Altman-Z score of 9.88. This indicates that ALAFY is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 9.88, ALAFY belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.02 indicates that ALAFY is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.02, ALAFY belongs to the top of the industry, outperforming 97.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 9.88
ROIC/WACCN/A
WACC7.77%
ALAFY.PA Yearly LT Debt VS Equity VS FCFALAFY.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 23.73 indicates that ALAFY has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 23.73, ALAFY belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • ALAFY has a Quick Ratio of 23.73. This indicates that ALAFY is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 23.73, ALAFY belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 23.73
Quick Ratio 23.73
ALAFY.PA Yearly Current Assets VS Current LiabilitesALAFY.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. ALAFY.PA Growth Analysis

3.1 Past

  • The earnings per share for ALAFY have decreased strongly by -41.96% in the last year.
  • Looking at the last year, ALAFY shows a very negative growth in Revenue. The Revenue has decreased by -20.58% in the last year.
  • The Revenue for ALAFY have been decreasing by -10.65% on average. This is quite bad
EPS 1Y (TTM)-41.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.56%
Revenue 1Y (TTM)-20.58%
Revenue growth 3Y-13.04%
Revenue growth 5Y-10.65%
Sales Q2Q%-28.64%

3.2 Future

  • ALAFY is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by 0.00% yearly.
  • Based on estimates for the next years, ALAFY will show a very negative growth in Revenue. The Revenue will decrease by -14.95% on average per year.
EPS Next Y27.27%
EPS Next 2Y14.15%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue Next Year-15.38%
Revenue Next 2Y-8.01%
Revenue Next 3Y-14.95%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALAFY.PA Yearly Revenue VS EstimatesALAFY.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1M 2M 3M 4M
ALAFY.PA Yearly EPS VS EstimatesALAFY.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -0.1 -0.2 -0.3 -0.4

More info and screens

Find the best growth stocksShow best growing peers

0

4. ALAFY.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALAFY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALAFY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALAFY.PA Price Earnings VS Forward Price EarningsALAFY.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALAFY.PA Per share dataALAFY.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.15%
EPS Next 3Y0%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALAFY.PA Dividend Analysis

5.1 Amount

  • No dividends for ALAFY!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALAFY.PA Fundamentals: All Metrics, Ratios and Statistics

AFYREN SAS

EPA:ALAFY (4/24/2026, 7:00:00 PM)

2.185

+0.09 (+4.3%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners8.35%
Inst Owner ChangeN/A
Ins Owners7.18%
Ins Owner ChangeN/A
Market Cap84.89M
Revenue(TTM)2.27M
Net Income(TTM)-14.37M
Analysts86
Price Target5.1 (133.41%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)5.88%
EPS NY rev (3m)25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-15.38%
Revenue NY rev (3m)-15.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 37.35
P/FCF N/A
P/OCF N/A
P/B 1.37
P/tB 1.43
EV/EBITDA N/A
EPS(TTM)-0.53
EYN/A
EPS(NY)-0.25
Fwd EYN/A
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS0.06
BVpS1.6
TBVpS1.53
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -21.4%
ROE -23.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 72.15%
FCFM N/A
ROA(3y)-17.22%
ROA(5y)-13.28%
ROE(3y)-19.05%
ROE(5y)-14.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.55%
GM growth 5Y-5.98%
F-Score3
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 22.61%
Cap/Sales 8.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 23.73
Quick Ratio 23.73
Altman-Z 9.88
F-Score3
WACC7.77%
ROIC/WACCN/A
Cap/Depr(3y)39.08%
Cap/Depr(5y)51.61%
Cap/Sales(3y)10.93%
Cap/Sales(5y)11.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-41.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.56%
EPS Next Y27.27%
EPS Next 2Y14.15%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue 1Y (TTM)-20.58%
Revenue growth 3Y-13.04%
Revenue growth 5Y-10.65%
Sales Q2Q%-28.64%
Revenue Next Year-15.38%
Revenue Next 2Y-8.01%
Revenue Next 3Y-14.95%
Revenue Next 5YN/A
EBIT growth 1Y-17.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year35.25%
EBIT Next 3Y-16.54%
EBIT Next 5YN/A
FCF growth 1Y0.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.52%
OCF growth 3YN/A
OCF growth 5YN/A

AFYREN SAS / ALAFY.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AFYREN SAS?

ChartMill assigns a fundamental rating of 2 / 10 to ALAFY.PA.


Can you provide the valuation status for AFYREN SAS?

ChartMill assigns a valuation rating of 0 / 10 to AFYREN SAS (ALAFY.PA). This can be considered as Overvalued.


What is the profitability of ALAFY stock?

AFYREN SAS (ALAFY.PA) has a profitability rating of 1 / 10.


How financially healthy is AFYREN SAS?

The financial health rating of AFYREN SAS (ALAFY.PA) is 6 / 10.